Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Being unregulated, the peptide vials one buys may be of questionable purity or dosage
Lixisenatide is potent at the GLP-1R and has a half-life of 34 h [22]
PubMed , Antioxidants & Redox Signaling , vol
Glass vials do not fully block UV light, and prolonged exposure to bright light can contribute to peptide degradation over weeks
Studies show just correlation, so far Experts say the latest data is still far from being able to conclude that GLP-1s are effective treatments for cancer
Obesity & Weight Management Segment is Expected to Drive the Oral Non-Peptide GLP-1 Receptor Agonist Market Obesity & Weight Management was another segment which had an important share in the global market for oral non-peptide GLP-1 receptor agonists in 2025
US$ 29.52
US$ 20.20
US$ 20.61
US$ 23.57
US$ 24.50
US$ 28.68
US$ 27.79
